Directory
Carlos Rodriguez Muñoz

Carlos Rodriguez Muñoz

Degree: Master’s degree

973702491
crodriguez(ELIMINAR)@irblleida.cat

Publications

  • Belmonte T; Rodríguez-Muñoz C; Ferruelo A; Exojo-Ramírez SM; Amado-Rodríguez L; Barbé F; de Gonzalo-Calvo D

    Exploring the translational landscape of the long noncoding RNA transcriptome in acute respiratory distress syndrome: it is a long way to the top.

    EUROPEAN RESPIRATORY REVIEW 33 -. .

    [doi:10.1183/16000617.0013-2024]

  • Belmonte, T; Perez-Pons, M; Benítez, ID; Molinero, M; García-Hidalgo, MC; Rodríguez-Muñoz, C; Gort-Paniello, C; Moncusí-Moix, A; Madè, A; Devaux, Y; Martelli, F; Ortega, A; González, J; Torres, G; Barbé, F; de Gonzalo-Calvo, D

    Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity

    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES 269 131926-131926. .

    [doi:10.1016/j.ijbiomac.2024.131926]

  • García-Hidalgo, MC; Benítez, ID; Perez-Pons, M; Molinero, M; Belmonte, T; Rodríguez-Muñoz, C; Aguilà, M; Santisteve, S; Torres, G; Moncusí-Moix, A; Gort-Paniello, C; Peláez, R; Larráyoz, IM; Caballero, J; Barbera, C; Nova-Lamperti, E; Torres, A; González, J; Barbé, F; de Gonzalo-Calvo, D

    MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study

    BRITISH JOURNAL OF PHARMACOLOGY -. .

    [doi:10.1111/bph.16330]

Projects

  • Deciphering the Pulmonary Sequelae in the POSTCOVID patient: Introducing the Endotype Concept.
  • Análisis de Endotipos Pulmonares en Pacientes Post-COVID: Un Es-tudio Integral
  • Ajuts Joan Oró per a la contractació de personal investigador predoctoral en formació FI 2024
  • Big Data para la predicción del riesgo de complicaciones durante y después del ingreso en pacientes crónicos con monitorización intensiva en las primeras 24h de ingreso.
  • A systems biology approach to understand COVID-19 physiopathology and predictits outcome (SYSTEMS-BIO COVID) (2021-046-1)